Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $57,290 | 43 | 48.0% |
| Travel and Lodging | $30,606 | 106 | 25.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,680 | 15 | 14.0% |
| Food and Beverage | $11,063 | 477 | 9.3% |
| Honoraria | $3,550 | 5 | 3.0% |
| Education | $111.70 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | $98,236 | 196 | $0 (2023) |
| Kyowa Kirin, Inc. | $11,935 | 23 | $0 (2024) |
| ABBVIE INC. | $2,523 | 28 | $0 (2023) |
| Novo Nordisk Inc | $1,855 | 92 | $0 (2024) |
| Dexcom, Inc. | $802.65 | 74 | $0 (2023) |
| Lilly USA, LLC | $635.04 | 37 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $351.96 | 17 | $0 (2024) |
| Merck Sharp & Dohme LLC | $334.28 | 21 | $0 (2023) |
| Tandem Diabetes Care, Inc. | $298.44 | 12 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $269.40 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,750 | 6 | Kyowa Kirin, Inc. ($1,575) |
| 2023 | $29,477 | 173 | Ultragenyx Pharmaceutical Inc. ($16,328) |
| 2022 | $73,518 | 280 | Ultragenyx Pharmaceutical Inc. ($70,425) |
| 2021 | $14,557 | 189 | Ultragenyx Pharmaceutical Inc. ($11,483) |
All Payment Transactions
648 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: DERMATOLOGY | ||||||
| 02/09/2024 | Kyowa Kirin, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| 01/25/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Growth Hormone | ||||||
| 01/08/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes | ||||||
| 01/04/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/21/2023 | Kyowa Kirin, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| 12/21/2023 | Kyowa Kirin, Inc. | — | Travel and Lodging | Cash or cash equivalent | $136.24 | General |
| 12/21/2023 | Kyowa Kirin, Inc. | — | Food and Beverage | Cash or cash equivalent | $96.21 | General |
| 12/21/2023 | Kyowa Kirin, Inc. | — | Food and Beverage | Cash or cash equivalent | $76.58 | General |
| 12/21/2023 | Kyowa Kirin, Inc. | — | Travel and Lodging | Cash or cash equivalent | $68.00 | General |
| 12/21/2023 | Kyowa Kirin, Inc. | — | Travel and Lodging | Cash or cash equivalent | $52.74 | General |
| 12/21/2023 | Kyowa Kirin, Inc. | — | Travel and Lodging | Cash or cash equivalent | $49.10 | General |
| 12/21/2023 | Kyowa Kirin, Inc. | — | Food and Beverage | Cash or cash equivalent | $39.33 | General |
| 12/21/2023 | Kyowa Kirin, Inc. | — | Food and Beverage | Cash or cash equivalent | $36.09 | General |
| 12/21/2023 | Kyowa Kirin, Inc. | — | Food and Beverage | Cash or cash equivalent | $33.58 | General |
| 12/21/2023 | Kyowa Kirin, Inc. | — | Food and Beverage | Cash or cash equivalent | $32.52 | General |
| 12/21/2023 | Kyowa Kirin, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.23 | General |
| 12/19/2023 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Growth Hormone | ||||||
| 12/15/2023 | Kyowa Kirin, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| 12/15/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.68 | General |
| 12/13/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/11/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes Care | ||||||
| 12/07/2023 | Kyowa Kirin, Inc. | — | Travel and Lodging | In-kind items and services | $550.68 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 915 | 1,608 | $137,046 | $45,959 |
| 2022 | 14 | 1,049 | 1,733 | $151,142 | $51,115 |
| 2021 | 17 | 1,338 | 2,079 | $187,872 | $72,886 |
| 2020 | 13 | 1,092 | 1,620 | $147,640 | $49,967 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 422 | $67,520 | $27,662 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 95 | $11,400 | $4,072 | 35.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 141 | 331 | $16,881 | $3,065 | 18.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 58 | 145 | $7,250 | $2,763 | 38.1% |
| 88172 | Evaluation of fine needle aspirate | Office | 2023 | 24 | 69 | $6,900 | $1,628 | 23.6% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 24 | 25 | $6,250 | $1,519 | 24.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 83 | 93 | $5,952 | $1,514 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 13 | $2,340 | $1,022 | 43.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 83 | 93 | $6,417 | $813.28 | 12.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 85 | 94 | $940.00 | $789.60 | 84.0% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 100 | 207 | $3,726 | $762.30 | 20.5% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 18 | 21 | $1,470 | $348.60 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 223 | 429 | $68,640 | $27,802 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 98 | 111 | $13,320 | $4,527 | 34.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 159 | 339 | $17,289 | $3,218 | 18.6% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 31 | 31 | $7,750 | $2,463 | 31.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 51 | 111 | $5,550 | $2,128 | 38.3% |
| 88172 | Evaluation of fine needle aspirate | Office | 2022 | 31 | 59 | $5,900 | $1,930 | 32.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 43 | $4,515 | $1,880 | 41.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 86 | 100 | $6,400 | $1,644 | 25.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 41 | 69 | $4,761 | $1,642 | 34.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $3,341 | $1,461 | 43.7% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 125 | 242 | $4,356 | $924.74 | 21.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 86 | 100 | $6,900 | $882.81 | 12.8% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2022 | 20 | 26 | $1,820 | $434.66 | 23.9% |
About Cory Davidson, PA-C
Cory Davidson, PA-C is a Medical healthcare provider based in Erie, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1235389412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cory Davidson, PA-C has received a total of $119,302 in payments from pharmaceutical and medical device companies, with $1,750 received in 2024. These payments were reported across 648 transactions from 45 companies. The most common payment nature is "Consulting Fee" ($57,290).
As a Medicare-enrolled provider, Davidson has provided services to 4,394 Medicare beneficiaries, totaling 7,040 services with total Medicare billing of $219,928. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Erie, PA
- Active Since 09/24/2008
- Last Updated 02/02/2024
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1235389412
Products in Payments
- Crysvita (Drug) $78,868
- CRYSVITA (Drug) $16,328
- SYNTHROID (Drug) $2,338
- Ozempic (Drug) $614.42
- Dexcom G6 Transmitter (Medical Supply) $577.42
- FARXIGA (Drug) $269.40
- t:slim X2 Insulin Pump with Control-IQ (Device) $264.93
- DEXCOM G6 TRANSMITTER (Device) $225.23
- Vascepa (Drug) $216.63
- BAQSIMI (Drug) $204.77
- STEGLATRO (Drug) $195.68
- LUPRON DEPOT (Drug) $167.31
- Korlym (Drug) $151.21
- SOLIQUA 100/33 (Biological) $148.30
- MOUNJARO (Drug) $141.16
- NATPARA (PARATHYROID HORMONE) (Drug) $125.00
- Saxenda (Drug) $122.46
- JARDIANCE (Drug) $121.29
- Triptodur (Drug) $119.23
- Kerendia (Drug) $112.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Erie
Miss. Emily Scavella, Pa-C, PA-C
Medical — Payments: $10,269
Amy Dudas, Pa, PA
Medical — Payments: $9,699
Ashley Kuneman, Pa-C, PA-C
Medical — Payments: $8,454
Sarah Patsy, Pa-C, PA-C
Medical — Payments: $8,430
Kaitlyn Ferguson, Pa-C, PA-C
Medical — Payments: $7,346
Mrs. Melanie Bentz, Pa-C, PA-C
Medical — Payments: $5,340